NCT01856790 - Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Type 1 Diabetes

Interventions

DEVICE

ePID closed loop system

Insulin pump controlled by closed loop unit and algorithm

DRUG

liraglutide

Liraglutide is a long-acting analog of human glucagon like peptide-1 (GLP-1) that works as a GLP-1 receptor agonist

Trial Locations (1)

Yale University School of Medicine, New Haven